The Effectiveness and Adverse Events of Cannabidiol and Tetrahydrocannabinol Used in the Treatment of Anxiety Disorders in a PTSD Subpopulation: An Interim Analysis of an Observational Study

Background: Anxiety is a condition for which current treatments are often limited by adverse events (AEs). Components of medicinal cannabis, cannabidiol (CBD) and tetrahydrocannabinol (THC), have been proposed as potential treatments for anxiety disorders, specifically posttraumatic stress disorder...

Descripción completa

Detalles Bibliográficos
Autores principales: Stack, Sophie K., Wheate, Nial J., Moloney, Niamh C., Abelev, Sarah V., Barlow, John W., Schubert, Elise A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387818/
https://www.ncbi.nlm.nih.gov/pubmed/37529155
http://dx.doi.org/10.1177/87551225231180796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387818/
https://www.ncbi.nlm.nih.gov/pubmed/37529155
http://dx.doi.org/10.1177/87551225231180796

Ejemplares similares